Airflow limitation in patients with heart failure: Prevalence and associated factors.
Limitación al flujo aéreo en pacientes con insuficiencia cardíaca: prevalencia y factores asociados.
Aged
Aged, 80 and over
Airway Obstruction
/ epidemiology
Biomarkers
Cause of Death
Comorbidity
Delayed Diagnosis
Female
Forced Expiratory Volume
Heart Failure
/ epidemiology
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Natriuretic Peptide, Brain
/ blood
Peptide Fragments
/ blood
Prevalence
Prospective Studies
Pulmonary Disease, Chronic Obstructive
/ diagnosis
Smoking
/ epidemiology
Spirometry
Airflow limitation
Chronic obstructive pulmonary disease
Comorbidity
Comorbilidad
Enfermedad pulmonar obstructiva crónica
Heart failure
Insuficiencia cardíaca
Limitación al flujo aéreo
Prevalence
Prevalencia
Prognosis
Pronóstico
Journal
Medicina clinica
ISSN: 1578-8989
Titre abrégé: Med Clin (Barc)
Pays: Spain
ID NLM: 0376377
Informations de publication
Date de publication:
13 09 2019
13 09 2019
Historique:
received:
15
08
2018
revised:
26
10
2018
accepted:
08
11
2018
pubmed:
9
1
2019
medline:
18
9
2020
entrez:
9
1
2019
Statut:
ppublish
Résumé
Chronic obstructive pulmonary disease and heart failure (HF) are 2 diseases with high morbidity and mortality. The coexistence of these two diseases is estimated to be frequent, but has been poorly studied. To study the prevalence of airflow limitation in a sample of patients diagnosed with HF in follow-up in an HF unit and to assess their characteristics and comorbidities. This is a prospective observational study. The patients who visited the HF Unit of the Hospital Universitari Germans Trias i Pujol between January 2014 and June 2015 were included consecutively. Respiratory functional tests were performed and clinical data were obtained. 118 patients were included in the study (age 67.2 years, 77.1% men). The prevalence of non-reversible airflow obstruction was 36.4%, with an underdiagnosis percentage of 67.4%. Patients with airflow limitation had an increase in comorbidities, but no worse prognosis. The prevalence of airflow limitation in patients with HF is high, with a significant degree of underdiagnosis. It seems reasonable to recommend performing a screening spirometry in these patients.
Sections du résumé
BACKGROUND
Chronic obstructive pulmonary disease and heart failure (HF) are 2 diseases with high morbidity and mortality. The coexistence of these two diseases is estimated to be frequent, but has been poorly studied.
AIM
To study the prevalence of airflow limitation in a sample of patients diagnosed with HF in follow-up in an HF unit and to assess their characteristics and comorbidities.
METHODS
This is a prospective observational study. The patients who visited the HF Unit of the Hospital Universitari Germans Trias i Pujol between January 2014 and June 2015 were included consecutively. Respiratory functional tests were performed and clinical data were obtained.
RESULTS
118 patients were included in the study (age 67.2 years, 77.1% men). The prevalence of non-reversible airflow obstruction was 36.4%, with an underdiagnosis percentage of 67.4%. Patients with airflow limitation had an increase in comorbidities, but no worse prognosis.
CONCLUSION
The prevalence of airflow limitation in patients with HF is high, with a significant degree of underdiagnosis. It seems reasonable to recommend performing a screening spirometry in these patients.
Identifiants
pubmed: 30616915
pii: S0025-7753(18)30744-9
doi: 10.1016/j.medcli.2018.11.016
pii:
doi:
Substances chimiques
Biomarkers
0
Peptide Fragments
0
pro-brain natriuretic peptide (1-76)
0
Natriuretic Peptide, Brain
114471-18-0
Types de publication
Journal Article
Observational Study
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
191-195Informations de copyright
Copyright © 2018 Elsevier España, S.L.U. All rights reserved.